Cargando…

Troglitazone Reduces Glyoxalase I Protein Expression in Glioma and Potentiates the Effects of Chemotherapeutic Agents

Despite resistance of most gliomas to chemotherapy, approximately 2/3 of oligodendrogliomas show sensitivity to such agents. This sensitivity has been associated with deletions on chromosome 1p alone or in combination with 19q. Higher expression of the enzyme glyoxalase I has been found in oligodend...

Descripción completa

Detalles Bibliográficos
Autores principales:	Helgager, Jeffrey, Li, Jie, Lubensky, Irina A., Lonser, Russell, Zhuang, Zhengping
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864507/ https://www.ncbi.nlm.nih.gov/pubmed/20454582 http://dx.doi.org/10.1155/2010/373491

Ejemplares similares

Dissecting the Physiological Function of Plant Glyoxalase I and Glyoxalase I-Like Proteins
por: Schmitz, Jessica, et al.
Publicado: (2018)

Novel glyoxalase-I inhibitors possessing a “zinc-binding feature” as potential anticancer agents
por: Al-Balas, Qosay A, et al.
Publicado: (2016)

Troglitazone and Δ2Troglitazone Enhance Adiponectin Expression in Monocytes/Macrophages through the AMP-Activated Protein Kinase Pathway
por: Tsai, Jaw-Shiun, et al.
Publicado: (2014)

In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer
por: Fujita, Megumi, et al.
Publicado: (2017)

Pharmacologic Modulation of Serine/Threonine Phosphorylation Highly Sensitizes PHEO in a MPC Cell and Mouse Model to Conventional Chemotherapy
por: Martiniova, Lucia, et al.
Publicado: (2011)

Effect of troglitazone on radiation sensitivity in cervix cancer cells
por: An, Zhengzhe, et al.
Publicado: (2012)

von Hippel-Lindau Disease-Associated Hemangioblastomas Are Derived from Embryologic Multipotent Cells
por: Park, Deric M, et al.
Publicado: (2007)

Polymorphisms in Glyoxalase I Gene Are Not Associated with Glyoxalase I Expression in Whole Blood or Markers of Methylglyoxal Stress: The CODAM Study
por: Maasen, Kim, et al.
Publicado: (2021)

Glyoxalase Goes Green: The Expanding Roles of Glyoxalase in Plants
por: Sankaranarayanan, Subramanian, et al.
Publicado: (2017)

Troglitazone reverses the multiple drug resistance phenotype in cancer cells
por: Davies, Gerald F, et al.
Publicado: (2009)

Troglitazone and tumor inhibition: an evolving concept in the management of systemic malignancies
por: Kapoor, Shailendra
Publicado: (2012)

Glyoxalase I Gene Deletion Mutants of Leishmania donovani Exhibit Reduced Methylglyoxal Detoxification
por: Chauhan, Swati C., et al.
Publicado: (2009)

Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosis
por: Hollenbach, Marcus, et al.
Publicado: (2017)

Salt-Tolerant Phenomena, Sequencing and Characterization of a Glyoxalase I (Jojo-Gly I) Gene from Jojoba in Comparison with Other Glyoxalase I Genes
por: Mohasseb, Heba Allah A., et al.
Publicado: (2020)

Inhibition of cell motility by troglitazone in human ovarian carcinoma cell line
por: Yang, Yuh-Cheng, et al.
Publicado: (2007)

Antiproliferative effects and molecular mechanisms of troglitazone in human cervical cancer in vitro
por: Ye, Jinjun, et al.
Publicado: (2015)

A Retrospective Review of Thiazolidinediones with Development of a Troglitazone Conversion Protocol
por: Lindsey, Cameron, et al.
Publicado: (2003)

Glyoxalases in Urological Malignancies
por: Antognelli, Cinzia, et al.
Publicado: (2018)

Emerging Glycation-Based Therapeutics—Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors
por: Rabbani, Naila, et al.
Publicado: (2022)

Glyoxalase 2: Towards a Broader View of the Second Player of the Glyoxalase System
por: Scirè, Andrea, et al.
Publicado: (2022)

Trk inhibition reduces cell proliferation and potentiates the effects of chemotherapeutic agents in Ewing sarcoma
por: Heinen, Tiago Elias, et al.
Publicado: (2016)

Glyoxalase I activity affects Arabidopsis sensitivity to ammonium nutrition
por: Borysiuk, Klaudia, et al.
Publicado: (2022)

Troglitazone Induces Extracellular Matrix and Cytoskeleton Remodeling in Mouse Collecting Duct Cells
por: Corinaldi, Jaime, et al.
Publicado: (2012)

Evaluation of Chemotherapeutic Agents
por: Engstrom, W. W.
Publicado: (1949)

Systems Pharmacology Modeling Predicts Delayed Presentation and Species Differences in Bile Acid-Mediated Troglitazone Hepatotoxicity
por: Yang, Kyunghee, et al.
Publicado: (2014)

Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines
por: Shen, Y-C, et al.
Publicado: (2004)

Expression analysis of glyoxalase I gene among patients of diabetic retinopathy
por: Rasul, Aneela, et al.
Publicado: (2018)

Common variants in glyoxalase I do not increase chronic pancreatitis risk
por: Kaune, Tom, et al.
Publicado: (2019)

Integrative Toxicoproteomics Implicates Impaired Mitochondrial Glutathione Import as an Off-Target Effect of Troglitazone
por: Lee, Yie Hou, et al.
Publicado: (2013)

Troglitazone Enhances the Apoptotic Response of DLD-1 Colon Cancer Cells to Photodynamic Therapy
por: Park, Hyunju, et al.
Publicado: (2016)

Inhibition of Glyoxalase-I Leads to Reduced Proliferation, Migration and Colony Formation, and Enhanced Susceptibility to Sorafenib in Hepatocellular Carcinoma
por: Michel, Maurice, et al.
Publicado: (2019)

Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas
por: Wang, Joshua L., et al.
Publicado: (2020)

FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agents
por: Patil, Abhijit A., et al.
Publicado: (2014)

Genome-Wide Expression Analysis of Glyoxalase I Genes Under Hyperosmotic Stress and Existence of a Stress-Responsive Mitochondrial Glyoxalase I Activity in Durum Wheat (Triticum durum Desf.)
por: Soccio, Mario, et al.
Publicado: (2022)

Increased Glyoxalase-1 Levels in Fkbp5 Knockout Mice Caused by Glyoxalase-1 Gene Duplication
por: Kollmannsberger, Lorenz K., et al.
Publicado: (2013)

Targeted Delivery of Chemotherapeutic Agents for Osteosarcoma Treatment
por: Xie, Duoli, et al.
Publicado: (2022)

Research progress of anti-glioma chemotherapeutic drugs
por: Zhou, Yi-Shu, et al.
Publicado: (2022)

Genome-Wide Identification of Cassava Glyoxalase I Genes and the Potential Function of MeGLYⅠ-13 in Iron Toxicity Tolerance
por: Tang, Fenlian, et al.
Publicado: (2022)

Troglitazone suppresses transforming growth factor beta-mediated fibrogenesis in retinal pigment epithelial cells
por: Cheng, Huey-Chuan, et al.
Publicado: (2008)

Troglitazone suppresses tumor cell growth and glutamine metabolism through a PPAR-independent mechanism
por: Reynolds, Miriam, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_puoc75lvepueq9okiqv4rn5lfb